Pharmaceutical Technology

SEPTEMBER 15, 2022

As a result of huge global sales of mRNA Covid-19 vaccines, the split in profits between Pfizer and BioNTech’s Comirnaty contributed towards revenues of $81.3bn and $22.4bn last year, respectively. Pfizer reaped $36.8bn from Comirnaty, the highest revenue generated from Covid-19 vaccine sales worldwide. YoY revenue growth.

Vaccination 272

Vaccination Vaccine Sales Generic Drugs 272

Pharmaceutical Technology

JULY 29, 2022

Pfizer has reported a 53% operational growth in revenues to $27.7bn in the second quarter (Q2) of 2022 compared to $18.9bn in the same quarter last year. On an operational basis, the revenues rose by $128m or 1%, excluding Paxlovid and Comirnaty’s contributions. Paxlovid alone delivered global sales of $8.1bn, the company noted.

Sales 264

Sales Development 264

BioTech 365

OCTOBER 17, 2021

Philips delivers Q3 sales of EUR 4.2 comparable sales decline due to headwinds; income from continuing operations increases to EUR 442 million, and Adjusted EBITA margin amounts to 12.3% Philips delivers Q3 sales of EUR 4.2 … Continue reading → billion, with a 7.6%

Sales 40

Sales 40

BioSpace

NOVEMBER 1, 2023

Riding a wave of skyrocketing Wegovy and Ozempic sales, the company on Thursday raised its sales and operating profit outlook for the rest of the year as part of its third-quarter earnings announcement.

Sales 102

Sales 102

pharmaphorum

APRIL 2, 2024

Acorda Therapeutics has filed for bankruptcy protection, hoping to keep operating while it tries to arrange the sale of its main assets to a US subsidiary of Germany’s Merz. The announcement made last night US time sparked a run on Acorda's shares, down almost 62% at the time of writing.

Sales 93

Sales 93

BioSpace

OCTOBER 23, 2023

The Swiss pharma reported a 12% sales increase and 21% core operating growth for the third quarter on Tuesday, while raising its full-year earnings forecast for the third time.

Sales 107

Sales 107

Pharmaceutical Technology

NOVEMBER 4, 2022

For the quarter, total product sales were recorded at $6.2bn, a 1% drop from $6.3bn in Q3 2021. The drop in global product sales led to the decline in total revenue for the third quarter of this year, the company noted. In the third quarter of 2022, non-GAAP operating income grew by 7% to $3.3bn from $3.1bn in Q3 2021.

Sales 130

Sales Production Licensing Licensing 130

Pharmaceutical Technology

APRIL 19, 2023

increase in sales to $24.75bn in the first quarter (Q1) of 2023, up from $23.4bn during the corresponding quarter of 2022. In the US, sales of J&J rose by 9.7% During this period, the company’s international sales grew by 1.8% from $12.01bn to $12.23bn, and worldwide sales rose by 5.6%. from $5.15bn in Q1 2022.

Sales 130

Sales Production Drugs 130

BioPharma Reporter

NOVEMBER 21, 2023

OSP was delighted to talk to Vetterâs Carsten Press, a senior leader of the global sales organization, and business development among many operational functions.

Branding 76

Branding Business Development Sales Development 76

Pharmaceutical Technology

OCTOBER 19, 2022

Johnson & Johnson (J&J) has reported sales of $23.79bn in the third quarter (Q3) of 2022, indicating an increase of 1.9% The reported sales in the US increased by 4.1% During this quarter, international sales saw a 0.3% decline, while worldwide sales rose by 1.9%. rise in sales to $23.3bn in Q3 2021.

Sales 130

Sales Drugs 130

Pharmaceutical Technology

APRIL 20, 2023

The firm reported 47% growth in sales from Q2 to Q4 in 2022, which is testament to CBC’s unique and effective investor-operator strategy. “We We are confident that the attractive entry valuation, coupled with strong operational and growth momentum, will create long-term sustainable value for CBC and our fellow shareholders.”

Development 246

Development Business Development Sales Drugs 246

Pharmaceutical Technology

OCTOBER 28, 2022

Merck (MSD outside North America) has reported a 14% rise in worldwide sales to $15bn in the third quarter (Q3) of 2022 as against $13.15bn in the year-ago quarter. For the quarter, pharmaceutical sales were recorded at $13bn compared to $12.7bn in Q3 2021, indicating a 13% growth. Sales from Lagevrio alone contributed to $436m.

Sales 130

Sales 130

Fierce Pharma

AUGUST 1, 2023

Paxlovid generated just $143 million in worldwide sales for the second quarter, while mRNA vaccine Comirnaty brought home $1.4 As COVID-19 revenues ebb and flow—but mostly ebb—Pfizer is eyeing the cost-cutting shears. Against that backdrop, Pfizer reported total second quarter revenues of $12.7

Sales 93

Sales Vaccination Vaccine 93

BioPharma Reporter

NOVEMBER 21, 2023

OSP was delighted to talk to Vetterâs Carsten Press, a senior leader of the global sales organization, and business development among many operational functions.

Business Development 52

Business Development Sales Development Drug Delivery 52

Pharmaceutical Technology

AUGUST 1, 2022

on an operational basis during the quarter. on an operational basis. Importantly, Skyrizi and Rinvoq continued their impressive ramps and are on pace to deliver approximately $7.5bn in combined annual sales, underscoring their significant potential. rise on a GAAP basis. Net revenue surged by 6.1% from $0.42 in Q2 2021.

Sales 246

Sales Production 246

Fierce Pharma

DECEMBER 4, 2023

million), to buy Sandoz’s China operations. | The move is expected to bring in some $95 million in annual sales, the company said. South Africa’s Aspen Pharmacare is growing its global footprint with a new agreement, worth up to 92.6 million euros ($100.3 In a separate deal, Sandoz snapped up four Aspen products for $60 million.

Sales 68

Sales Production 68

Fierce Pharma

OCTOBER 20, 2023

With a new chief operating officer and an ongoing generics hit to its longtime stalwart Xyrem, Jazz Pharma has been going through some changes this year. | The company is in talks with advisors to field interest in a potential sale, people with knowledge of the matter told Bloomberg.

Sales 77

Sales 77

Pharmaceutical Technology

MARCH 14, 2023

The company stated that the deal covers most facets of the commercialisation process, including medical communications, marketing, medical affairs, sales, commercial operations support, regulatory, pricing, reimbursement, market access (PRMA), and pharmacovigilance.

FDA Approval 147

FDA Approval Sales Life Science Marketing 147

BioSpace

JULY 29, 2021

As Gilead gets ready to open its doors to its new operations site in North Carolina, the company reported its product sales for the second quarter increased 21% year-over-year primarily driven by Veklury.

Sales 97

Sales Production 97

XTalks

MARCH 15, 2022

Hundreds of companies have announced plans to suspend or halt operations in Russia amid the ongoing war with Ukraine, many of which are well-known Western food companies. and Nestlé SA, have suspended operations in Russia following the country’s invasion of Ukraine. Among them include food giants like General Mills, Nestlé and Cargill.

Sales 98

Sales Branding Packaging Packaging 98

The Pharma Data

AUGUST 7, 2021

Operating profit decreased by 1% in Danish kroner and increased by 9% at constant exchange rates (CER). Sales increased by 5% in Danish kroner and by 12% at CER to DKK 66.8 Sales within Diabetes and Obesity care increased by 5% in Danish kroner to DKK 56.9 In June 2021, Wegovy , semaglutide 2.4 12% N/A. * 12% N/A. *

Sales 52

Sales Drugs 52

STAT News

NOVEMBER 9, 2022

Clovis Oncology, a maker of cancer drugs, warned Wednesday that it will likely file for bankruptcy protection due to dwindling sales of its sole product, mounting financial losses, and a crushing debt load.

Sales 98

Sales Production Drugs 98

XTalks

MAY 15, 2023

Scheduled to commence construction this year, the 100-acre plant will become fully operational by 2025 and will be strategically situated between two key US dairy-producing regions, Rochester and Niagara. Fairlife currently owns and operates two production facilities in the US in Coopersville, Michigan and Goodyear, Arizona.

Sales 98

Sales Protein Branding Containment 98

Pharmaceutical Technology

APRIL 11, 2023

The company stated that azithromycin tablets generated annual sales of $20m in the US. It carries out operations in the regulated markets of the US and Europe, as well as in Latin America and South Africa. Zydus, which currently has 360 approvals, has filed abbreviated new drug applications for more than 440 drugs since 2003-04.

FDA Approval 130

FDA Approval Drugs Immune Response Manufacturing 130

pharmaphorum

JANUARY 24, 2023

“Expanding our operations at Research Triangle Park will accelerate the rate at which we can produce medicines that patients rely on to address serious health challenges like diabetes,” said Edgardo Hernandez, head of Lilly’s manufacturing operations.

Sales 87

Sales FDA Approval Packaging Packaging 87

Drug Discovery World

FEBRUARY 23, 2024

Sphere Fluidics has welcomed Dr Graeme Daniels as its new Vice President of Sales and Marketing, bringing over 20 years of experience in the life sciences and biotechnology industries. CN Bio has added Joseph Parisi as US Director of Sales. Cancer Research Horizons has made two additions to its board of directors.

Drugs 59

Drugs Life Science Sales Genome 59

Cloudbyz

OCTOBER 25, 2023

Naperville, Illinois – October 24, 2023 : Cloudbyz, an innovative digital clinical research solutions provider, today announced a new partnership with SPAR Solutions who provide a complete range of customer engagement solutions covering sales, marketing, service, and communities.

Life Science 89

Life Science Clinical Trials Clinical Trials Compliance 89

The Pharma Data

OCTOBER 26, 2021

Ex-US sales grew +3% (cc). billion (+64% USD) , with higher operating income, lower payments out of provisions and favorable changes in working capital. billion (+64% USD) , with higher operating income, lower payments out of provisions and favorable changes in working capital. Innovative Medicines net sales were USD 10.6

Medicine 52

Medicine Sales Marketing Generic Pharmaceutical 52

Drug Discovery World

NOVEMBER 2, 2022

GSK has announced strong quarterly results, reporting sales of £7.8 Overall, the company’s adjusted operating profit for the third quarter came in at £2.6 Going forward, GSK expects a strong fourth quarter, with continued high sales and what it describes as an increase in its R&D spending. . Vaccines . Official comments.

Sales 52

Sales Vaccination Vaccine Medicine 52

pharmaphorum

FEBRUARY 3, 2022

Novartis chief executive Vas Narasimhan has downplayed any chances of swift decision on the future of its generics business Sandoz, saying that a decision on the possible sale of the unit may not come until the last quarter of the year. Psoriasis blockbuster Cosentyx (secukinumab) continued to deliver with a 12% rise in sales to $1.2

Sales 96

Sales Gene Therapy Production Gene 96

BioTech 365

OCTOBER 27, 2020

Q3 net sales from continuing operations1were in line with prior year (cc2, +1% USD): Growth drivers included Entresto USD 632 million (+45% cc), Zolgensma USD 291 million (+79% cc), Cosentyx USD 1 012 million (+7% cc), Kisqali USD 183 million … Continue reading →

Sales 40

Sales 40

XTalks

JULY 6, 2023

The deal, which values Kevin’s at approximately $800 million, was pursued after Kevin’s explored various options, including a potential sale earlier this year. “We Headquartered in McLean, Virginia, Mars operates three major divisions: Mars Petcare, Mars Snacking and Mars Food & Nutrition.

Branding 96

Branding Sales Packaging Packaging 96

BioSpace

JUNE 22, 2021

CEO Emma Walmsley’s vision includes a projected $46 billion in annual sales from the stand-alone pharma company by 2031 and more than 10% operating profit over the next five years.

Pharma Companies 64

Pharma Companies Sales 64

Pharmaceutical Technology

NOVEMBER 21, 2022

billion) in total sales in 2021 and is expected to grow 1.1% Among the 37 member companies, 17 of them are overseas companies and 20 of them are Japanese companies with a 10%+ overseas pharma sales ratio. Other reasons include lower sales demand and high investment costs. in 2022 to JPY9.498 trillion ($68.08

Marketing 173

Marketing Sales Manufacturing Drugs 173

Pharmaceutical Technology

FEBRUARY 24, 2023

Applying the drug’s phase transition success rate to remaining R&D costs and likelihood of approval (LoA) to sales related costs provides a risk-adjusted NPV model (rNPV). It also promotes products through sales representatives and marketing agreements with other pharmaceutical companies. over FY2021. million in FY2021.

Sales 113

Sales Production Clinical Trials Clinical Trials 113

XTalks

SEPTEMBER 1, 2023

GlaxoSmithKline (GSK) has been pumping large sums of cash into expanding its vaccine manufacturing operations and today, it announced an investment of €250 ($272 million) into building a new unit for freeze-drying vaccines at its Wavre campus in Belgium. In the first half of 2023, sales of the vaccine grew by 16 percent to £1.7

Vaccination 98

Vaccination Vaccine Manufacturing Production 98

Pharmaceutical Technology

FEBRUARY 20, 2023

Applying the drug’s phase transition success rate to remaining R&D costs and likelihood of approval (LoA) to sales related costs provides a risk-adjusted NPV model (rNPV). The company supplies its products through internal sales, distributors, and an internal marketing group in the US and outside the US. million in FY2020.

Sales 100

Sales Clinical Trials Clinical Trials Development 100